ArticleFrontiers in immunology2022

Bioactive Lipids as Chronic Myeloid Leukemia's Potential Biomarkers for Disease Progression and Response to Tyrosine Kinase Inhibitors.

Felipe Campos de Almeida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.